Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-03-0100PMID 14871994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Butyrate-induced G , Arrest Results from p 21-independent Disruption of Retinoblastoma Protein-mediated Signals 1

  2005cited by this paper
• Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.

  2003cited by this paper
• Class II histone deacetylases: versatile regulators.

  2003cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study.

  2003cited by this paper
• Sodium butyrate induces growth arrest and senescence‐like phenotypes in gynecologic cancer cells

  2001cited by this paper
• Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

  2001cited by this paper
• Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

  2000cited by this paper
• Rapid Induction of Histone Hyperacetylation and Cellular Differentiation in Human Breast Tumor Cell Lines following Degradation of Histone Deacetylase-1*

  2000cited by this paper
• Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

  2000cited by this paper
• Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

  2000cited by this paper
• Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells.

  2000cited by this paper
• Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer

  2000cited by this paper
• DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

  2000cited by this paper
• The language of covalent histone modifications

  2000cited by this paper
• Inhibition of Mitogenesis in Balb/c-3T3 Cells by Trichostatin A

  2000cited by this paper
• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

  1999cited by this paper
• Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

  1999cited by this paper
• Histone deacetylase inhibitors as potential anti-skin cancer agents.

  1999cited by this paper
• Cyclins and cell cycle checkpoints.

  1999cited by this paper
• Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.

  1999cited by this paper
• Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.

  1999cited by this paper
• Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I.

  1999cited by this paper
• Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

  1999cited by this paper
• Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.

  1999cited by this paper
• Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.

  1998cited by this paper
• ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

  1998cited by this paper
• Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

  1998cited by this paper
• Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO

  1998cited by this paper
• The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.

  1998cited by this paper
• Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.

  1998cited by this paper
• Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein

  1998cited by this paper
• Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells.

  1997cited by this paper
• Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression.

  1997cited by this paper
• Direct inhibition of the expression of cyclin D1 gene by sodium butyrate.

  1996cited by this paper
• A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

  1996cited by this paper
• The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

  1996cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function

  1995cited by this paper
• Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities

  1995cited by this paper
• Transcription: in tune with the histones.

  1994cited by this paper
• Chromatin as an essential part of the transcriptional mechanim

  1992cited by this paper
• Cadherin cell adhesion receptors as a morphogenetic regulator.

  1991cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper
• Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells.

  1990cited by this paper
• Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1

  1988cited by this paper
• Mechanism of anticonvulsant action of valproate

  1982cited by this paper

• Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells

  2025cites this paper
• Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells

  2025cites this paper
• Butyrate as a Potential Modulator in Gynecological Disease Progression

  2024cites this paper
• Improving therapeutic potential in breast cancer via histone deacetylase inhibitor loaded nanofibrils

  2024cites this paper
• Predicting drug response from single-cell expression profiles of tumours

  2023cites this paper
• Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder

  2023cites this paper
• Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3/SLC7A11 axis

  2023cites this paper
• Incentive Nursing can Effectively Improve the ESCA Level of Patients with Endometrial Cancer after Laparoscopic Hysterectomy

  2022cites this paper
• PSRR: A Web Server for Predicting the Regulation of miRNAs Expression by Small Molecules

  2022cites this paper
• Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies

  2022cites this paper
• Vorinostat (SAHA) and Breast Cancer: An Overview

  2021cites this paper
• Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis

  2021cites this paper
• Identification of Significant Gene Expression Changes in Multiple Perturbation Experiments using Knockoffs

  2021cites this paper
• Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma

  2021cites this paper
• Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma

  2021cites this paper
• Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer.

  2021cites this paper
• Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications

  2021cites this paper
• An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway

  2020cites this paper
• Suberoylanilide hydroxamic acid attenuates epidural fibrosis via inhibiting myofibroblast differentiation and increasing fibroblast apoptosis.

  2020cites this paper
• An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway

  2020cites this paper
• Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma

  2020cites this paper
• Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro

  2020cites this paper
• Profound Inhibitory and Apoptotic Effects of Histone Deacetylase Inhibitor Valproic Acid on Different Cancers

  2019cites this paper
• Transient gene expression using valproic acid in combination with co‐transfection of SV40 large T antigen and human p21CIP/p27KIP

  2019cites this paper
• Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1.

  2019cites this paper
• p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death

  2019cites this paper
• Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy

  2019cites this paper
• Zebularine significantly improves the preimplantation development of ovine somatic cell nuclear transfer embryos.

  2019cites this paper
• Endometriosis Pathoetiology and Pathophysiology: Roles of Vitamin A, Estrogen, Immunity, Adipocytes, Gut Microbiome and Melatonergic Pathway on Mitochondria Regulation

  2019cites this paper
• Molecular/Targeted Therapy of Cancer

  2019cites this paper
• Structure, Function, and Evaluation of the Female Reproductive Tract

  2019cites this paper
• HDAC1 overexpression enhances β-cell proliferation by down-regulating Cdkn1b/p27.

  2018cites this paper
• Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

  2018influential citation
• A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation

  2018cites this paper
• Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.

  2018cites this paper
• Cancer metabolism: New insights into classic characteristics

  2017cites this paper
• Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Anti-Proliferation Effects in Hepatocellular Carcinoma Cells

  2017cites this paper
• Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells

  2017cites this paper
• Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition

  2017cites this paper
• HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells

  2017cites this paper
• Identification of a novel miRNA that increases transient protein expression in combination with valproic acid

  2017cites this paper
• Cell Signaling and Epigenetic Mechanisms in Mesothelioma

  2017cites this paper
• Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

  2017cites this paper
• Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor β-Deficient Colon Cancer

  2017cites this paper
• Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases

  2016cites this paper
• Comparison of Anticancer Effects of Carbamazepine and Valproic Acid

  2016cites this paper
• Epigenetic regulation of epithelial–mesenchymal transition

  2016cites this paper
• Valproic acid ( VPA ) suppresses the expression of SMAD 4 in prostate carcinoma by up-regulating miR-34 a

  2016cites this paper
• N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

  2016cites this paper
• SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin

  2016cites this paper
• Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices.

  2016cites this paper
• Phase I trial of valproic acid and lenalidomide in patients with advanced cancer

  2015cites this paper
• Endometrial Cancer Stem Cell as a Potential Therapeutic Target

  2015cites this paper
• Epigenetics in Cancer Metastasis

  2015cites this paper
• Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4

  2015cites this paper
• Epigenetic inhibitors.

  2015cites this paper
• The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals

  2015cites this paper
• Intercellular Communication in Cancer

  2015cites this paper
• Dynamic Regulation of Adherens Junctions: Implication in Cell Differentiation and Tumor Development

  2015cites this paper
• Cancer Epigenetics

  2015cites this paper
• Targeted therapy in gynecologic cancers: Ready for prime time?

  2015cites this paper
• An investigation into the potential use of the histone deacetylase inhibitor, valproic acid for the prevention of gastric cancer in high-risk families

  2015cites this paper
• Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7–HMGA2–Cyclin A2 Pathway

  2015cites this paper
• The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome – a proof-of-concept study

  2015cites this paper
• Valproic acid-induced histone acetylation suppresses CYP19 gene expression and inhibits the growth and survival of endometrial stromal cells.

  2015cites this paper
• Effects of Scriptaid on Cell Cycle and Histone Acetylation of Ovine Nuclear Donor Cumulus Cells and their Ability to Support the Development of Somatic Cell Nuclear Transfer Embryos

  2015cites this paper
• Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases.

  2015cites this paper
• Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro

  2015cites this paper
• Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity

  2015cites this paper
• Assessment of Notch1 ligands production - key protein targets in breast cancer

  2014cites this paper
• Valproic acid suppresses growth and enhances cisplatin cytotoxicity to larynx cancer cells

  2014cites this paper
• Multi-Layered Epigenetic Regulatory Mechanisms Mediate Epithelial toMesenchymal Transition in Cancer

  2014cites this paper
• HDAC as a therapeutic target for treatment of endometrial cancers.

  2014cites this paper
• Effect of butyrate on immune response of a chicken macrophage cell line.

  2014cites this paper
• Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance

  2014cites this paper
• Anti-Epileptic Drug Targets Ewing Sarcoma.

  2014cites this paper
• Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.

  2013cites this paper
• Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo

  2013cites this paper
• New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)

  2013cites this paper
• Combination of Vorinostat and caspase‐8 inhibition exhibits high anti‐tumoral activity on endometrial cancer cells

  2013cites this paper
• Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

  2013influential citation
• Epigenetic regulation of epithelial to mesenchymal transition.

  2013cites this paper
• HDAC inhibitors in experimental liver and kidney fibrosis

  2013cites this paper
• Current status of molecular-targeted drugs for endometrial cancer (Review)

  2013cites this paper
• Genetic Variations of ABCC2 Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients

  2013cites this paper
• Sodium Valproate Induces Cell Senescence in Human Hepatocarcinoma Cells

  2013cites this paper
• OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesis.

  2013cites this paper
• Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.

  2013cites this paper
• Epigenetic targeting therapies to overcome chemotherapy resistance.

  2013cites this paper
• Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer

  2013cites this paper
• Molecular Mechanisms of Hereditary Diffuse Gastric Cancer Initiation and Progression

  2013cites this paper
• HDAC inhibitors: applications in oncology and beyond

  2013cites this paper
• Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.

  2013cites this paper
• RETRACTED ARTICLE: Calcium/calmodulin-dependent kinase inhibitor induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells

  2012cites this paper
• Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line

  2012cites this paper
• Endometrial cancer stem cells: a new target for cancer therapy.

  2012cites this paper
• Valproic acid inhibits proliferation of EB virus-infected natural killer cells

  2012cites this paper
• Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.

  2012cites this paper
• Antitumor activities of valproic acid on Epstein–Barr virus‐associated T and natural killer lymphoma cells

  2012cites this paper
• Novel molecular targeted therapies for refractory thyroid cancer

  2012cites this paper